Double-dose hepatitis B vaccination in people with HIV

Affiliations

¹ Infectious Diseases Division, Scripps Mercy Hospital, San Diego, CA 92103, USA; Naval Medical Center, San Diego, CA, USA. Electronic address: nancy32red@yahoo.com.
² Infectious Diseases, Skagit Valley Hospital, Mount Vernon, WA, USA.

Comment

Nancy F Crum-Cianflone et al. Lancet Infect Dis. 2015 Nov.

. 2015 Nov;15(11):1245-6.

doi: 10.1016/S1473-3099(15)00240-6. Epub 2015 Aug 6.

¹ Infectious Diseases Division, Scripps Mercy Hospital, San Diego, CA 92103, USA; Naval Medical Center, San Diego, CA, USA. Electronic address: nancy32red@yahoo.com.
² Infectious Diseases, Skagit Valley Hospital, Mount Vernon, WA, USA.

No abstract available

Comment on

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Rey D, et al. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6. Lancet Infect Dis. 2015. PMID: 26257021 Clinical Trial.